Literature DB >> 500941

Pulmonary and systemic haemodynamic disorders in the adult respiratory distress syndrome.

F Jardin, F Gurdjian, J L Fouilladieu, B Goudot, A Margairaz.   

Abstract

Entities:  

Mesh:

Year:  1979        PMID: 500941     DOI: 10.1007/bf01683194

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  17 in total

1.  Circulatory data in normal subjects at rest and during exercise in recumbent position, with special reference to the stroke volume at different work intensities.

Authors:  A HOLMGREN; B JONSSON; T SJOSTRAND
Journal:  Acta Physiol Scand       Date:  1960-08-25

2.  Cardiac output and related measurements and pressure values in the right heart and associated vessels, together with an analysis of the hemo-dynamic response to the inhalation of high oxygen mixtures in healthy subjects.

Authors:  B G BARRATT-BOYES; E H WOOD
Journal:  J Lab Clin Med       Date:  1958-01

3.  Central haemodynamics during exercise in patients with restrictive pulmonary disease.

Authors:  J Widimsky; M Riedel; V Stanek
Journal:  Bull Eur Physiopathol Respir       Date:  1977 May-Jun

4.  [Letter: Is PaO2 under pure oxygen a reliable criterium of pulmonary oxygen transfer during respiratory assistance using a membrane oxygenator].

Authors:  F Lemaire; B Teisseire; A Harari; D Loisance
Journal:  Nouv Presse Med       Date:  1974-09-07

5.  Sepsis complicating the acute respiratory distress syndrome.

Authors:  D G Ashbaugh; T L Petty
Journal:  Surg Gynecol Obstet       Date:  1972-12

6.  Energy metabolism in sepsis: treatment based on different patterns in shock and high output stage.

Authors:  G H Clowes; T F O'Donnell; N T Ryan; G L Blackburn
Journal:  Ann Surg       Date:  1974-05       Impact factor: 12.969

7.  Vascular obstruction causes pulmonary hypertension in severe acute respiratory failure.

Authors:  W M Zapol; K Kobayashi; M T Snider; R Greene; M B Laver
Journal:  Chest       Date:  1977-02       Impact factor: 9.410

8.  Shock lung with massive tracheal loss of plasma.

Authors:  L B Pemberton
Journal:  JAMA       Date:  1977-06-06       Impact factor: 56.272

9.  Immediate and middle-term cardiorespiratory effects of positive end-expiratory pressure in thirteen cases of non-haemodynamic pulmonary oedema.

Authors:  F Jardin; F Gurdjian; M C Eveleight; J L Fouilladieu; A Margairaz
Journal:  Resuscitation       Date:  1978       Impact factor: 5.262

10.  Pulmonary gas exchange during venoarterial bypass with a membrane lung for acute respiratory failure.

Authors:  F Lemaire; F Jardin; B Regnier; D Loisance; B Goudot; F Lange; M C Eveleigh; B Teisseire; D Laurent; M Rapin
Journal:  J Thorac Cardiovasc Surg       Date:  1978-06       Impact factor: 5.209

View more
  5 in total

1.  Pharmacological treatment of pulmonary oedema.

Authors:  J Carlet; M Francoual; F Lhoste; B Regnier; F Lemaire
Journal:  Intensive Care Med       Date:  1980       Impact factor: 17.440

2.  Is there a safe plateau pressure in ARDS? The right heart only knows.

Authors:  François Jardin; Antoine Vieillard-Baron
Journal:  Intensive Care Med       Date:  2007-02-01       Impact factor: 17.440

Review 3.  Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome.

Authors:  Magda Cepkova; Michael A Matthay
Journal:  J Intensive Care Med       Date:  2006 May-Jun       Impact factor: 3.510

4.  [Early PEEP for improvement of prognosis in patients with acute respiratory insufficiency (author's transl)].

Authors:  L S Weilemann; H P Schuster; C J Schuster; C Rey; J Majdandzic
Journal:  Klin Wochenschr       Date:  1981-06-15

5.  Clinical significance of elevated B-type natriuretic peptide in patients with acute lung injury with or without right ventricular dilatation: an observational cohort study.

Authors:  Magda Cepkova; Vineet Kapur; Xiushui Ren; Thomas Quinn; Hanjing Zhuo; Elyse Foster; Michael A Matthay; Kathleen D Liu
Journal:  Ann Intensive Care       Date:  2011-06-13       Impact factor: 6.925

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.